A new algorithm designed by HMS scientists can be incorporated into standard genetic tests to successfully identify patients harboring a tumor-fueling DNA repair defect found in multiple cancers treatable with existing drugs.

In the largest study of U.S. twins to date, researchers use insurance records to tease out the effects of genes and the environment in 560 diseases.